131 related articles for article (PubMed ID: 34096882)
1. 'You cannot expect miracles to happen overnight': patience pays off when you wish to establish a new adrenocortical carcinoma cell line.
Lalli E
Eur J Endocrinol; 2021 Jul; 185(2):C9-C11. PubMed ID: 34096882
[TBL] [Abstract][Full Text] [Related]
2. A novel patient-derived cell line of adrenocortical carcinoma shows a pathogenic role of germline MUTYH mutation and high tumour mutational burden.
Landwehr LS; Schreiner J; Appenzeller S; Kircher S; Herterich S; Sbiera S; Fassnacht M; Kroiss M; Weigand I
Eur J Endocrinol; 2021 May; 184(6):823-835. PubMed ID: 33830941
[TBL] [Abstract][Full Text] [Related]
3. Familial Adrenocortical Carcinoma in Association With Lynch Syndrome.
Challis BG; Kandasamy N; Powlson AS; Koulouri O; Annamalai AK; Happerfield L; Marker AJ; Arends MJ; Nik-Zainal S; Gurnell M
J Clin Endocrinol Metab; 2016 Jun; 101(6):2269-72. PubMed ID: 27144940
[TBL] [Abstract][Full Text] [Related]
4. TP53 germline mutations in adult patients with adrenocortical carcinoma.
Herrmann LJ; Heinze B; Fassnacht M; Willenberg HS; Quinkler M; Reisch N; Zink M; Allolio B; Hahner S
J Clin Endocrinol Metab; 2012 Mar; 97(3):E476-85. PubMed ID: 22170717
[TBL] [Abstract][Full Text] [Related]
5. Identification of a novel TP53 germline mutation E285V in a rare case of paediatric adrenocortical carcinoma and choroid plexus carcinoma.
Russell-Swetek A; West AN; Mintern JE; Jenkins J; Rodriguez-Galindo C; Ribeiro R; Zambetti GP
J Med Genet; 2008 Sep; 45(9):603-6. PubMed ID: 18762572
[TBL] [Abstract][Full Text] [Related]
6. First case report of an adrenocortical carcinoma caused by a BRCA2 mutation.
El Ghorayeb N; Grunenwald S; Nolet S; Primeau V; Côté S; Maugard CM; Lacroix A; Gaboury L; Bourdeau I
Medicine (Baltimore); 2016 Sep; 95(36):e4756. PubMed ID: 27603373
[TBL] [Abstract][Full Text] [Related]
7. Mutational signature analysis identifies MUTYH deficiency in colorectal cancers and adrenocortical carcinomas.
Pilati C; Shinde J; Alexandrov LB; Assié G; André T; Hélias-Rodzewicz Z; Ducoudray R; Le Corre D; Zucman-Rossi J; Emile JF; Bertherat J; Letouzé E; Laurent-Puig P
J Pathol; 2017 May; 242(1):10-15. PubMed ID: 28127763
[TBL] [Abstract][Full Text] [Related]
8. Integrative computational immunogenomic profiling of cortisol-secreting adrenocortical carcinoma.
Baechle JJ; Hanna DN; Sekhar KR; Rathmell JC; Rathmell WK; Baregamian N
J Cell Mol Med; 2021 Nov; 25(21):10061-10072. PubMed ID: 34664400
[TBL] [Abstract][Full Text] [Related]
9. Adrenocortical carcinoma (ACC): When and why should we consider germline testing?
Petr EJ; Else T
Presse Med; 2018; 47(7-8 Pt 2):e119-e125. PubMed ID: 30104051
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and functional consequence of TP53 mutations in pediatric adrenocortical carcinoma: a children's oncology group study.
Wasserman JD; Novokmet A; Eichler-Jonsson C; Ribeiro RC; Rodriguez-Galindo C; Zambetti GP; Malkin D
J Clin Oncol; 2015 Feb; 33(6):602-9. PubMed ID: 25584008
[TBL] [Abstract][Full Text] [Related]
11. Genomic stratification and liquid biopsy in a rare adrenocortical carcinoma (ACC) case, with dual lung metastases.
McCabe MJ; Pinese M; Chan CL; Sheriff N; Thompson TJ; Grady J; Wong M; Gauthier MA; Puttick C; Gayevskiy V; Hajdu E; Wong SQ; Barrett W; Earls P; Lukeis R; Cheng YY; Lin RCY; Thomas DM; Watkins DN; Dinger ME; McCormack AI; Cowley MJ
Cold Spring Harb Mol Case Stud; 2019 Apr; 5(2):. PubMed ID: 30936196
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of Adrenocortical Carcinoma Associated With Lynch Syndrome.
Domènech M; Grau E; Solanes A; Izquierdo A; Del Valle J; Carrato C; Pineda M; Dueñas N; Pujol M; Lázaro C; Capellà G; Brunet J; Navarro M
J Clin Endocrinol Metab; 2021 Jan; 106(2):318-325. PubMed ID: 33185660
[TBL] [Abstract][Full Text] [Related]
13. Ataxia telangiectasia mutated germline pathogenic variant in adrenocortical carcinoma.
Torres MB; Diggs LP; Wei JS; Khan J; Miettinen M; Fasaye GA; Gillespie A; Widemann BC; Kaplan RN; Davis JL; Hernandez JM; Rivero JD
Cancer Genet; 2021 Aug; 256-257():21-25. PubMed ID: 33836455
[TBL] [Abstract][Full Text] [Related]
14. Analysis of m6A-Related Signatures in the Tumor Immune Microenvironment and Identification of Clinical Prognostic Regulators in Adrenocortical Carcinoma.
Jin Y; Wang Z; He D; Zhu Y; Hu X; Gong L; Xiao M; Chen X; Cheng Y; Cao K
Front Immunol; 2021; 12():637933. PubMed ID: 33746977
[TBL] [Abstract][Full Text] [Related]
15. Expression of FSCN1 and FOXM1 are associated with poor prognosis of adrenocortical carcinoma patients.
Liang J; Liu Z; Wei X; Zhou L; Tang Y; Zhou C; Wu K; Zhang F; Zhang F; Lu Y; Zhu Y
BMC Cancer; 2019 Nov; 19(1):1165. PubMed ID: 31783819
[TBL] [Abstract][Full Text] [Related]
16. Adrenocortical carcinoma and succinate dehydrogenase gene mutations: an observational case series.
Else T; Lerario AM; Everett J; Haymon L; Wham D; Mullane M; Wilson TL; Rainville I; Rana H; Worth AJ; Snyder NW; Blair IA; McKay R; Kilbridge K; Hammer G; Barletta J; Vaidya A
Eur J Endocrinol; 2017 Nov; 177(5):439-444. PubMed ID: 28819017
[TBL] [Abstract][Full Text] [Related]
17. Combined steroidogenic characters of fetal adrenal and Leydig cells in childhood adrenocortical carcinoma.
Fujisawa Y; Sakaguchi K; Ono H; Yamaguchi R; Kato F; Kagami M; Fukami M; Ogata T
J Steroid Biochem Mol Biol; 2016 May; 159():86-93. PubMed ID: 26940356
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of germline TP53 mutations in a prospective series of unselected patients with adrenocortical carcinoma.
Raymond VM; Else T; Everett JN; Long JM; Gruber SB; Hammer GD
J Clin Endocrinol Metab; 2013 Jan; 98(1):E119-25. PubMed ID: 23175693
[TBL] [Abstract][Full Text] [Related]
19. Establishment and characterization of the first pediatric adrenocortical carcinoma xenograft model identifies topotecan as a potential chemotherapeutic agent.
Pinto EM; Morton C; Rodriguez-Galindo C; McGregor L; Davidoff AM; Mercer K; Debelenko LV; Billups C; Ribeiro RC; Zambetti GP
Clin Cancer Res; 2013 Apr; 19(7):1740-7. PubMed ID: 23406775
[TBL] [Abstract][Full Text] [Related]
20. Rottlerin as a novel chemotherapy agent for adrenocortical carcinoma.
Zhu Y; Wang M; Zhao X; Zhang L; Wu Y; Wang B; Hu W
Oncotarget; 2017 Apr; 8(14):22825-22834. PubMed ID: 28423559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
